In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2 - Concepedia

Concepedia

Publication | Open Access

In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2

DOI Full Paper Access

34

Citations

39

References

2022

Year

Rana Gbyli, Yuanbin Song, Wei Liu, Yimeng Gao, Giulia Biancon, Namrata S. Chandhok, Xiaman Wang, Xiaoying Fu, Amisha Patel, Ranjini K. Sundaram,

Mutant Idh1/2Parp InhibitionChemoprevention StrategyMedicineAnti-cancer AgentVivo Anti-tumor EffectPharmacologyRadiation OncologyCancer ResearchTumor BiologyDrug Discovery

References

	Year	Citations

Page 1

Page 1